X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs FULFORD INDIA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER FULFORD INDIA PFIZER/
FULFORD INDIA
 
P/E (TTM) x 29.1 398.8 7.3% View Chart
P/BV x 4.6 6.2 74.4% View Chart
Dividend Yield % 0.7 0.1 827.8%  

Financials

 PFIZER   FULFORD INDIA
EQUITY SHARE DATA
    PFIZER
Mar-16
FULFORD INDIA
Mar-14
PFIZER/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs2,724942 289.2%   
Low Rs1,611450 358.0%   
Sales per share (Unadj.) Rs440.9691.4 63.8%  
Earnings per share (Unadj.) Rs48.711.5 424.9%  
Cash flow per share (Unadj.) Rs75.815.4 493.3%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %0.70.3 240.8%  
Book value per share (Unadj.) Rs462.9380.0 121.8%  
Shares outstanding (eoy) m45.753.90 1,173.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.0 488.4%   
Avg P/E ratio x44.560.7 73.3%  
P/CF ratio (eoy) x28.645.3 63.1%  
Price / Book Value ratio x4.71.8 255.6%  
Dividend payout %30.817.4 176.5%   
Avg Mkt Cap Rs m99,1632,714 3,653.2%   
No. of employees `0002.90.4 650.7%   
Total wages/salary Rs m2,758505 546.0%   
Avg. sales/employee Rs Th6,981.76,073.0 115.0%   
Avg. wages/employee Rs Th954.51,137.4 83.9%   
Avg. net profit/employee Rs Th771.1100.7 765.9%   
INCOME DATA
Net Sales Rs m20,1702,696 748.0%  
Other income Rs m857125 683.7%   
Total revenues Rs m21,0282,822 745.2%   
Gross profit Rs m4,310-46 -9,288.4%  
Depreciation Rs m1,23915 8,149.3%   
Interest Rs m510 54.7%   
Profit before tax Rs m3,92354 7,225.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,79410 18,691.7%   
Profit after tax Rs m2,22845 4,983.8%  
Gross profit margin %21.4-1.7 -1,241.7%  
Effective tax rate %45.717.7 258.7%   
Net profit margin %11.01.7 666.3%  
BALANCE SHEET DATA
Current assets Rs m16,2991,738 937.6%   
Current liabilities Rs m7,594545 1,394.1%   
Net working cap to sales %43.244.3 97.5%  
Current ratio x2.13.2 67.3%  
Inventory Days Days6548 134.7%  
Debtors Days Days264 598.2%  
Net fixed assets Rs m8,62212 72,452.9%   
Share capital Rs m45839 1,173.1%   
"Free" reserves Rs m20,7221,443 1,436.1%   
Net worth Rs m21,1801,482 1,429.1%   
Long term debt Rs m250-   
Total assets Rs m29,1372,077 1,403.0%  
Interest coverage x755.56.7 11,249.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.3 53.3%   
Return on assets %7.72.6 293.6%  
Return on equity %10.53.0 348.7%  
Return on capital %19.04.3 441.2%  
Exports to sales %0.10-   
Imports to sales %17.524.5 71.5%   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,526659 534.8%   
Fx inflow Rs m5217 300.3%   
Fx outflow Rs m140673 20.8%   
Net fx Rs m-88-656 13.5%   
CASH FLOW
From Operations Rs m3,43690 3,818.1%  
From Investments Rs m-6,991105 -6,683.5%  
From Financial Activity Rs m-619-14 4,388.7%  
Net Cashflow Rs m-4,174181 -2,312.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 3.8 197.4%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 21.2 111.8%  
Shareholders   85,207 4,783 1,781.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   CIPLA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; IT Stocks Top Gainers(01:30 pm)

After opening the day marginally higher, share markets in India continued the momentum and are presently trading in green. Sectoral indices are trading on a mixed note, with stocks in the IT sector.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 22, 2018 03:33 PM

TRACK PFIZER

PFIZER - MERCK LTD COMPARISON

COMPARE PFIZER WITH

MARKET STATS